BDBM492885 N-(4-carbamoylbenzyl)- 5-(4-((2-oxopyridin- 1(2H)- yl)methyl)benzyl) nicotinamide::US10981893, Example 14

SMILES NC(=O)c1ccc(CNC(=O)c2cncc(Cc3ccc(Cn4ccccc4=O)cc3)c2)cc1

InChI Key InChIKey=HLHWFYOMXOFERK-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 492885   

TargetPlasma kallikrein(Homo sapiens (Human))
Attune Pharmaceuticals

US Patent
LigandPNGBDBM492885(N-(4-carbamoylbenzyl)- 5-(4-((2-oxopyridin- 1(2H)-...)
Affinity DataIC50:  5.50E+3nMAssay Description:The ability of the compounds disclosed herein to inhibit human plasma kallikrein activity was quantified according to the procedures below.A 10 mM so...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent